Propofol: An immunomodulating agent

Pharmacotherapy

Volumn 25, Issue 5 II, 2005, Pages

  Marik, Paul E ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Antioxidant; Cytokines; EDTA; Ethylenediaminetetraacetic acid; Lipid peroxidation; Metabisulfite; Nitric oxide; Nuclear factor B; Propofol

Indexed keywords

ANTIOXIDANT; CYTOKINE; EDETIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYPNOTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOMODULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; N(G) METHYLARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OMEGA 3 FATTY ACID; PRESERVATIVE; PROPOFOL; SODIUM METABISULFITE; SOYBEAN OIL; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANESTHESIA INDUCTION; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BACTERIAL GROWTH; CLINICAL TRIAL; CYTOKINE PRODUCTION; DRUG FORMULATION; DRUG POTENCY; DRUG SOLUBILITY; EMULSION; HUMAN; INTENSIVE CARE UNIT; LIPID PEROXIDATION; NEUTROPHIL; NONHUMAN; RAT; REVIEW; SEDATION; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANESTHETICS, INTRAVENOUS; ANTIOXIDANTS; CHELATING AGENTS; CHEMISTRY, PHARMACEUTICAL; EDETIC ACID; EMULSIONS; HUMANS; HYPNOTICS AND SEDATIVES; IMMUNOLOGIC FACTORS; LIPID PEROXIDATION; PROPOFOL;

EID: 18044393206     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.2005.25.5_Part_2.28S     Document Type: Review

References (87)

1. 2 reactivity of brain vessels in the human. Anaesthesist 1987;36:60-5.
2. Hartung HJ. Intracranial pressure in patients with craniocerebral trauma after administration of propofol and thiopental. Anaesthesist 1987;36:285-7.
3. Hartung HJ. Modification of intracranial pressure by propofol (Disoprivan). Initial results. Anaesthesist 1987;36:66-8.
4. Ravussin P, Guinard JP, Ralley F, Thorin D. Effect of propofol on cerebrospinal fluid pressure and cerebral perfusion pressure in patients undergoing craniotomy. Anaesthesia 1988;43(suppl):37-41.
5. Vandesteene A, Trempont V, Engelman E, et al. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia 1988;43(suppl):42-3.
6. Kochs E, Hoffman WE, Werner C, Thomas C, Albrecht RF, Schulte am Esch J. The effects of propofol on brain electrical activity, neurologic outcome, and neuronal damage following incomplete ischemia in rats. Anesthesiology 1992;76:245-52.
7. Gelb AW, Zhang C, Henderson SM. A comparison of the cerebral protective effects of propofol, thiopental, and halothane in temporary feline focal cerebral ischemia [abstr]. Anesth Analg 1993;76:S115.
8. Ridenour TR, Warner DS, Todd MM, Gionet TX. Comparative effects of propofol and halothane on outcome from temporary middle cerebral artery occlusion in the rat. Anesthesiology 1992;76:807-12.
9. Amorim P, Chambers G, Cottrell J, Kass IS. Propofol reduces neuronal transmission damage and attenuates the changes in calcium, potassium, and sodium during hyperthermic anoxia in the rat hippocampal slice. Anesthesiology 1995;83:1254-65.
10. Wang J, Yang X, Camporesi CV, et al. Propofol reduces infarct size and striatal dopamine accumulation following transient middle cerebral artery occlusion: a microdialysis study. Eur J Pharmacol 2002;452:303-8.
11. Young Y, Menon DK, Tisavipat N, Matta BF, Jones JG. Propofol neuroprotection in a rat model of ischaemia reperfusion injury. Eur J Anaesthesiol 1997;14:320-6.
12. Gelb AW, Bayona NA, Wilson JX, Cechetto DF. Propofol anesthesia compared to awake reduces infarct size in rats. Anesthesiology 2002;96:1183-90.
13. Ergun R, Akdemir G, Sen S, Tasci A, Ergungor F. Neuroprotective effects of propofol following global cerebral ischemia in rats. Neurosurg Rev 2002;25:95-8.
14. Yamasaki T, Nakakimura K, Matsumoto M, Xiong L, Ishikawa T, Sakabe T. Effects of graded suppression of the EEG with propofol on the neurological outcome following incomplete cerebral ischaemia in rats. Eur J Anaesthesiol 1999;16:320-9.
15. Yamaguchi S, Midorikawa Y, Okuda Y, Kitajima T. Propofol prevents delayed neuronal death following transient forebrain ischemia in gerbils. Can J Anaesth 1999;46:593-8.
16. Marik PE, Varon J, Trask T. Management of head trauma. Chest 2002;122:699-711.
17. Marik PE, Varon J. The management of status epilepticus. Chest 2004;126:582-91.
18. Pedersen CM, Thirstrup S, Nielsen-Kudsk JE. Smooth muscle relaxant effects of propofol and ketamine in isolated guinea-pig trachea. Eur J Pharmacol 1993;238:75-80.
19. Ouedraogo N, Marthan R, Roux E. The effects of propofol and etomidate on airway contractility in chronically hypoxic rats. Anesth Analg 2003;96:1035-41.
20. Hashiba E, Sato T, Hirota K, Hashimoto Y, Matsuki A. The relaxant effect of propofol on guinea pig tracheal muscle is independent of airway epithelial function and beta-adrenoceptor activity. Anesth Analg 1999;89:191-6.
21. Hirota K, Sato T. Relaxant effect of propofol on the airway in dogs [abstr]. Anesthesiology 1997;87:A1116.
22. Gasparetto A, Conti G. Intravenous anesthetics and respiratory mechanics [in Italian]. Minerva Anestesiol 1992;58:843-4.
23. Pizov R, Brown RH, Weiss YS, et al. Wheezing during induction of general anesthesia in patients with and without asthma: a randomized, blinded trial. Anesthesiology 1995;82:1111-16.
24. Eames WO, Rooke GA, Wu RS, Bishop MJ. Comparison of the effects of etomidate, propofol, and thiopental on respiratory resistance after tracheal intubation. Anesthesiology 1996;84:1307-11.
25. Zaloga G, Todd N, Levit P, et al. Propofol induced bronchodilation in patients with status asthmaticus. Internet J Emerg Intensive Care Med 5. Available from http://wwwicaap.org/iuicode?89.5.5.5 2001. Accessed June 4, 2003.
26. Conti G, Dell'Utri D, Vilardi V, et al. Propofol induces bronchodilation in mechanically ventilated chronic obstructive pulmonary disease (COPD) patients. Acta Anaesthesiol Scand 1993;37:105-9.
27. Conti G, Ferretti A, Tellan G, Rocco M, Lappa A. Propofol induces bronchodilation in a patient mechanically ventilated for status asthmaticus [abstr]. Intensive Care Med 1993;19:305.
28. Marik PE, Varon J, Fromm R Jr. The management of acute severe asthma. J Emerg Med 2002;23:257-68.
29. Taniguchi T, Yamamoto K, Ohmoto N, Ohta K, Kobayashi T. Effects of propofol on hemodynamic and inflammatory responses to endotoxemia in rats. Crit Care Med 2000;28:1101-6.
30. Taniguchi T, Kanakura H, Yamamoto K. Effects of post-treatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 2002;30:904-7.
31. Taniguchi T, Kanakura H, Takemoto Y, Kidani Y, Yamamoto K. Effects of ketamine and propofol on the ratio of interleukin-6 to interleukin-10 during endotoxemia in rats. Tohoku J Exp Med 2003;200:85-92.
32. Galley HF, Dubbels AM, Webster NR. The effect of midazolam and propofol on interleukin-8 from human polymorphonuclear leukocytes. Anesth Analg 1998;86:1289-93.
33. Takaono M, Yogosawa T, Okawa-Takatsuji M, Aotsuka S. Effects of intravenous anesthetics on interleukin (IL)-6 and IL-10 production by lipopolysaccharide-stimulated mononuclear cells from healthy volunteers. Acta Anaesthesiol Scand 2002;46:176-9.
34. Gao J, Zeng BX, Zhou LJ, Yuan SY. Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Br J Anaesth 2004;92:277-9.
35. Gao J, Zeng B, Zhou L, Yuan S, Zhang S. Therapeutic effect of propofol in the treatment of endotoxin-induced shock in rats. J Huazhong Univ Sci Technolog Med Sci 2003;23:320-3.
36. Kwak SH, Choi JI, Park JT. Effects of propofol on endotoxin-induced acute lung injury in rabbit. Korean Med Sci 2004;19:55-61.
37. Mikawa K, Akamatsu H, Nishina K, et al. Propofol inhibits human neutrophil functions. Anesth Analg 1998;87:695-700.
38. Hofbauer R, Frass M, Salfinger H, et al. Propofol reduces the migration of human leukocytes through endothelial cell monolayers. Crit Care Med 1999;27:1843-7.
39. Fourcade O, Simon MF, Litt L, Samii K, Chap H. Propofol inhibits human platelet aggregation induced by proinflammatory lipid mediators. Anesth Analg 2004;99:393-8.
40. Herr DL, Kelly K, Hall JB, et al. Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients. Intensive Care Med 2000;26(suppl 4):S452-62.
41. Malcolm DS, Zaloga GP, Holaday JW. Calcium administration increases the mortality of endotoxic shock in rats. Crit Care Med 1989;17:900-3.
42. Zaloga GP, Sager A, Black KW, Prielipp R. Low dose calcium administration increases mortality during septic peritonitis in rats. Circ Shock 1992;37:226-9.
43. Black RA. Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol 2002;34:1-5.
44. Brock JH. Benefits and dangers of iron during infection. Curr Opin Clin Nutr Metab Care 1999;2:507-10.
45. Jurado RL. Iron, infections, and anemia of inflammation. Clin Infect Dis 1997;25:888-95.
46. Xiong S, She H, Sung CK, Tsukamoto H. Iron-dependent activation of NF-kB in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol 2003;30:107-13.
47. Xiong S, She H, Takeuchi H, et al. Signaling role of intracellular iron in NF-kB activation. J Biol Chem 2003;278:17646-54.
48. She H, Xiong S, Lin M, Zandi E, Giulivi C, Tsukamoto H. Iron activates NF-kB in Kupffer cells. Am J Physiol Gastrointest Liver Physiol 2002;283:G719-26.
49. Vulcano M, Meiss RP, Isturiz MA. Deferoxamine reduces tissue injury and lethality in LPS-treated mice. Int J Immunopharmacol 2000;22:635-44.
50. Ghafourifar P, Richter C. Nitric oxide synthase activity in mitochondria. FEBS Lett 1997;418:291-6.
51. Giulivi C, Poderoso JJ, Boveris A. Production of nitric oxide by mitochondria. J Biol Chem 1998;273:11038-43.
52. Annane D, Sanquer S, Sebille V, et al. Compartmentalised inducible nitric-oxide synthase activity in septic shock. Lancet 2000;355:1143-8.
53. Lanone S, Mebazaa A, Heymes C, et al. Sepsis is associated with reciprocal expressional modifications of constitutive nitric oxide synthase (NOS) in human skeletal muscle: down-regulation of NOS1 and up-regulation of NOS3. Crit Care Med 2001;29:1720-5.
54. Cunha FQ, Assreuy J, Moss DW, et al. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1 beta. Immunology 1994;81:211-15.
55. Mikawa K, Nishina K, Kodama S, Obara H. Propofol attenuates diaphragmatic dysfunction induced by septic peritonitis in hamsters. Anesthesiology 2001;94:652-60.
56. Peng Z, Luo M, Ye S, et al. Antioxidative and anti-endotoxin effects of propofol on endothelial cells. Chin Med J 2003;116:731-5.
57. Chen RM, Wu GJ, Tai YT, et al. Propofol reduces nitric oxide biosynthesis in lipopolysaccharide-activated macrophages by downregulating the expression of inducible nitric oxide synthase. Arch Toxicol 2003;77:418-23.
58. Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30.
59. Watson D, Grover R, Anzueto A, et al. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Crit Care Med 2004;32:13-20.
60. Green TR, Bennett SR, Nelson VM. Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 1994;129:163-9.
61. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992;68:613-18.
62. Kahraman S, Demiryurek AT. Propofol is a peroxynitrite scavenger. Anesth Analg 1997;84:1127-9.
63. Murphy PG, Bennett JR, Myers DS, Davies MJ, Jones JG. The effect of propofol anaesthesia on free radical-induced lipid peroxidation in rat liver microsomes. Eur J Anaesthesiol 1993;10:261-6.
64. Musacchio E, Rizzoli V, Bianchi M, Bindoli A, Galzigna L. Antioxidant action of propofol on liver microsomes, mitochondria and brain synaptosomes in the rat. Pharmacol Toxicol 1991;69:75-7.
65. Xia Z, Godin DV, Chang TK, Ansley DM. Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation. Can J Physiol Pharmacol 2003;81:14-21.
66. Kahraman S, Kilinc K, Dal D, Erdem K. Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury. Br J Anaesth 1997;78:279-81.
67. Sayin MM, Ozatamer O, Tasoz R, Kilinc K, Unal N. Propofol attenuates myocardial lipid peroxidation during coronary artery bypass grafting surgery. Br J Anaesth 2002;89:242-6.
68. Xia Z, Godin DV, Ansley DM. Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F(2t)-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 2003;59:113-21.
69. Basu S, Mutschler DK, Larsson AO, Kiiski R, Nordgren A, Eriksson MB. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 2001;50:341-8.
70. Runzer TD, Ansley DM, Godin DV, Chambers GK. Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model. Anesth Analg 2002;94:89-93.
71. Kaptanoglu E, Sen S, Beskonakli E, et al. Antioxidant actions and early ultrastructural findings of thiopental and propofol in experimental spinal cord injury. J Neurosurg Anesthesiol 2002;14:114-22.
72. Stamford JA, Isaac D, Hicks CA, Ward MA, Osborne DJ, O'Neill MJ. Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data. Brain Res 1999;835:229-40.
73. Daskalopoulos R, Korcok J, Tao L, Wilson JX. Accumulation of intracellular ascorbale from dehydroascorbic acid by astrocytes is decreased after oxidative stress and restored by propofol. Glia 2002;39:124-32.
74. Southerland WM, Akogyeram CO, Toghrol F, Sloan L, Scherrer R. Interaction of bisulfite with unsaturated fatty acids. J Toxicol Environ Health 1982;10:479-91.
75. Baker MT, Gregerson MS, Martin SM, Buettner GR. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite. Crit Care Med 2003;31:787-92.
76. Baker MT, Dehring DJ, Gregerson MS. Sulfite supported lipid peroxidation in propofol emulsions. Anesthesiology 2002;97:1162-7.
77. Baker MT, Gregerson MS, Naguib M. Role of lipid in sulfite-dependent propofol dimerization. Anesthesiology 2004;100:1235-41.
78. Furukawa K. Soybean oil, stress response, and immune function: a clinical study. Nutrition 2003;19:212.
79. Furukawa K, Yamamori H, Takagi K, et al. Influences of soybean oil emulsion on stress response and cell-mediated immune function in moderately or severely stressed patients. Nutrition 2002;18:235-40.
80. Furukawa K, Tashiro T, Yamamori H, et al. Effects of soybean oil emulsion and eicosapentaenoic acid on stress response and immune function after a severely stressful operation. Ann Surg 1999;229:255-61.
81. Hayashi N, John M. Kinney international awards, a summary of our work: effects of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. Nutrition 2001;17:211.
82. Hayashi N, Tashiro T, Yamamori H, et al. Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. Nutrition 1999;15:135-9.
83. Hayashi N, Tashiro T, Yamamori H, et al. Effects of intravenous omega-3 and omega-6 fat emulsion on cytokine production and delayed type hypersensitivity in burned rats receiving total parenteral nutrition. J Parenter Enteral Nutr 1998;22:363-7.
84. Tashiro T, Yamamori H, Takagi K, Hayashi N, Furukawa K, Nakajima N. n-3 versus n-6 polyunsaturated fatty acids in critical illness. Nutrition 1998;14:551-3.
85. Song D, Hamza MA, White PF, Byerly SI, Jones SB, Macaluso AD. Comparison of a lower-lipid propofol emulsion with the standard emulsion for sedation during monitored anesthesia care. Anesthesiology 2004;100:1072-5.
86. Song D, Hamza M, White PF, Klein K, Recart A, Khodaparast O. The pharmacodynamic effects of a lower-lipid emulsion of propofol: a comparison with the standard propofol emulsion. Anesth Analg 2004;98:687-91.
87. Knibbe CA, Naber H, Aarts LP, Kuks PF, Danhof M. Long-term sedation with propofol 60 mg ml(-1) vs. propofol 10 mg ml(-1) in critically ill, mechanically ventilated patients. Acta Anaesthesiol Scand 2004;48:302-7.